Myecfo »

Arrowhead Pharmaceuticals shares owned by Myecfo

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Myecfo from 13F filings

Historical chart of Myecfo investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Myecfo consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Myecfo

Quarter filed Position value Share count Share price at filing
2024-03-31 $529k 19k 28.60

More positions owned by Myecfo

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Calif Mun Bd Etf (CMF)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Schwab Strategic Tr Int-trm U.s Tres (SCHR)
Schwab Strategic Tr Mun Bd Etf (SCMB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr New York Mun Etf (NYF)
Pimco Etf Tr Inv Grd Crp Bd (CORP)
Ishares Tr National Mun Etf (MUB)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Apple (AAPL)
Ishares Tr Gnma Bond Etf (GNMA)

View all positions for Myecfo

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
FMR
Artal Group
Geode Capital Management
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Credit Suisse
Northern Trust
Rokos Capital Management
Pictet Asset Management Holding SA
Morgan Stanley
venBio Select Advisor
Bank of New York Mellon
Goldman Sachs Group

View all funds holding Arrowhead Pharmaceuticals